MedPath

Preservation of Seminal Ejaculation during Endoscopic Surgery for Prostatic Enlargement

Not Applicable
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2019/04/018557
Lead Sponsor
All India Institute of Medical Sciences Bhubaneswar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a) Patients with active sexual life and ability to ejaculate.

b) Written informed consent.

c) Patients with benign prostatic hyperplasia with any one of the following:

c.1) Lower urinary tract symptoms who had failed standard medical therapy (alpha blockers, 5 alpha reductase inhibitors)

c.2) Recurrent urinary retention (drug-refractory)

c.3) Recurrent urinary tract infection

c.4) Recurrent hematuria

Exclusion Criteria

a) ASA Grade 3 or more.

b) Suspected or confirmed malignancy of prostate, upper or lower urinary tract.

c) Neurological diseases or neurogenic bladder and voiding dysfunction.

d) Concomitant urethral stricture.

e) Bilateral upper tract dilatation with or without elevation of creatinine.

f) Pelvic pain syndrome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The ejaculatory and erectile function after ejaculation preserving and conventional transurethral resection of prostate.Timepoint: 1. Preoperatively <br/ ><br>2. 3 months after Surgery
Secondary Outcome Measures
NameTimeMethod
Ejaculation Projection ScoreTimepoint: 1. Preoperatively <br/ ><br>2. 3 months after Surgery;IPSS ScoreTimepoint: 1. Preoperatively <br/ ><br>2. 3 months after Surgery;Maximum Flow rate (Qmax) <br/ ><br>Timepoint: 1. Preoperatively <br/ ><br>2. 3 months after Surgery;Post Void ResidueTimepoint: 1. Preoperatively <br/ ><br>2. 3 months after Surgery
© Copyright 2025. All Rights Reserved by MedPath